Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Eribulin in Advanced or Recurrent Cervical Cancer
NCT01676818Phase 2Completed
- Sponsor
- University of Southern California
- Start
- Aug 2012
- Primary completion
- Feb 2021
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of eribulin in Cervical Cancer (CC), sponsored by University of Southern California. Started Aug 2012; status: completed.
02
Drugs
eribulin
03
Conditions
Cervical Cancer (CC)
Beyond the preview
Go deeper on NCT01676818.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01676818.